{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:39:59Z","timestamp":1792435199712,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16463-8","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:13:59Z","timestamp":1784722439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differentiating Xp11.2\/TFE3 translocation renal cell carcinoma from clear cell carcinoma: performance of a radiomics model"],"prefix":"10.1186","volume":"26","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuqiang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"6","key":"16463_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","volume":"34","author":"K Trpkov","year":"2021","unstructured":"Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, et al. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021;34(6):1167\u201384. https:\/\/doi.org\/10.1038\/s41379-021-00737-6.","journal-title":"Mod Pathol"},{"issue":"6","key":"16463_CR2","doi-asserted-by":"publisher","first-page":"188823","DOI":"10.1016\/j.bbcan.2022.188823","volume":"1877","author":"M Rizzo","year":"2022","unstructured":"Rizzo M, Pezzicoli G, Santoni M, Cali\u00f2 A, Martignoni G, et al. MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management. Biochim Biophys Acta Rev Cancer. 2022;1877(6):188823. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188823.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"16463_CR3","doi-asserted-by":"publisher","unstructured":"Tang J, Baba M. MiT\/TFE family Renal Cell Carcinoma. Genes (Basel). 2023;14(1). https:\/\/doi.org\/10.3390\/genes14010151.","DOI":"10.3390\/genes14010151"},{"key":"16463_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/cancers12061387","volume":"12","author":"R Suarez-Ibarrola","year":"2020","unstructured":"Suarez-Ibarrola R, Basulto-Martinez M, Heinze A, Gratzke C, Miernik A. Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature. Cancers. 2020;12:1387. https:\/\/doi.org\/10.3390\/cancers12061387.","journal-title":"Cancers"},{"key":"16463_CR5","doi-asserted-by":"publisher","first-page":"1266630","DOI":"10.3389\/fmed.2023.1266630","volume":"10","author":"W Huang","year":"2023","unstructured":"Huang W, Peng Y, Zhang Y, Qiu Y, Liu Y, et al. Multimodality imaging of Xp11.2 translocation\/TFE3 gene fusion associated with renal cell carcinoma: a case report. Front Med (Lausanne). 2023;10:1266630. https:\/\/doi.org\/10.3389\/fmed.2023.1266630.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"16463_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/jcrt.jcrt_1505_22","volume":"19","author":"H Dong","year":"2023","unstructured":"Dong H, Ni Y, Liu Z, Wang Z, Hu B, et al. Imaging findings, clinical and pathological characters of 28 patients with Xp11.2\/TFE3 translocation renal cell carcinoma. J Cancer Res Ther. 2023;19(1):132\u201340. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1505_22.","journal-title":"J Cancer Res Ther"},{"key":"16463_CR7","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.sipas.2025.100322","volume":"24","author":"S Samenezhad","year":"2025","unstructured":"Samenezhad S, Rafighi D. The role of artificial intelligence in advancing urologic care: From diagnostics to therapeutics. Surg Pract Sci. 2025;24:100322. https:\/\/doi.org\/10.1016\/j.sipas.2025.100322.","journal-title":"Surg Pract Sci"},{"issue":"4","key":"16463_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/jmri.27900","volume":"55","author":"Q Xu","year":"2022","unstructured":"Xu Q, Zhu Q, Liu H, Chang L, Duan S, et al. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists. J Magn Reson Imaging. 2022;55(4):1251\u20139. https:\/\/doi.org\/10.1002\/jmri.27900.","journal-title":"J Magn Reson Imaging"},{"key":"16463_CR9","doi-asserted-by":"publisher","unstructured":"Kim TM, Ahn H, Lee HJ, Kim MG, Cho JY et al. Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics. Abdom Radiol. 2022;47(8):2867\u20132880. https:\/\/doi.org\/10.1007\/s00261-022-03571-9.","DOI":"10.1007\/s00261-022-03571-9"},{"key":"16463_CR10","doi-asserted-by":"publisher","first-page":"1169922","DOI":"10.3389\/fonc.2023.1169922","volume":"13","author":"T Zhao","year":"2023","unstructured":"Zhao T, Sun Z, Guo Y, Sun Y, Zhang Y, et al. Automatic renal mass segmentation and classification on CT images based on 3D U-Net and ResNet algorithms. Front Oncol. 2023;13:1169922. https:\/\/doi.org\/10.3389\/fonc.2023.1169922.","journal-title":"Front Oncol"},{"key":"16463_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-4608(91)90184-v","volume":"57","author":"GE Tomlinson","year":"1991","unstructured":"Tomlinson GE, Nisen PD, Timmons CF, Schneider NR. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet. 1991;57:11\u20137. https:\/\/doi.org\/10.1016\/0165-4608(91)90184-v.","journal-title":"Cancer Genet Cytogenet"},{"issue":"10","key":"16463_CR12","doi-asserted-by":"publisher","first-page":"300060520942095","DOI":"10.1177\/0300060520942095","volume":"48","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang Y, Feng M, Lian X, Lei Y, et al. Renal cell carcinoma associated with Xp11.2 translocation\/transcription factor E3 gene fusion: an adult case report and literature review. J Int Med Res. 2020;48(10):300060520942095. https:\/\/doi.org\/10.1177\/0300060520942095.","journal-title":"J Int Med Res"},{"issue":"1","key":"16463_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12894-025-01908-2","volume":"20","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Shen J, Wu J, Huang H, Meng F, et al. Diagnosis and management of TFE3-rearranged renal cell carcinoma: case report and literature review. BMC Urol. 2025;20(1):207. https:\/\/doi.org\/10.1186\/s12894-025-01908-2.","journal-title":"BMC Urol"},{"issue":"1","key":"16463_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12894-022-01060-1","volume":"22","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhao L, Yang Z, Chen YH, Wu XR, et al. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation\/TFE3 gene fusion renal cell carcinomas. BMC Urol. 2022;22(1):109. https:\/\/doi.org\/10.1186\/s12894-022-01060-1.","journal-title":"BMC Urol"},{"issue":"4","key":"16463_CR15","doi-asserted-by":"publisher","first-page":"e37072","DOI":"10.7759\/cureus.37072","volume":"15","author":"P Kalita","year":"2023","unstructured":"Kalita P, Dey B, Saurabh A, Chishti SF. Xp11.2 Translocation Renal Cell Carcinoma: A Rare Renal Cell Carcinoma. Cureus. 2023;15(4):e37072. https:\/\/doi.org\/10.7759\/cureus.37072.","journal-title":"Cureus"},{"key":"16463_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pathol.2019.11.006","volume":"52","author":"A Calio","year":"2020","unstructured":"Calio A, Brunelli M, Segala D, Pedron S, Remo A, et al. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. Pathology. 2020;52:297\u2013309. https:\/\/doi.org\/10.1016\/j.pathol.2019.11.006.","journal-title":"Pathology"},{"key":"16463_CR17","doi-asserted-by":"publisher","first-page":"5647933","DOI":"10.1155\/2021\/5647933","volume":"2021","author":"J Dong","year":"2021","unstructured":"Dong J, Xu W, Ji Z, Pan B. Xp11.2 Translocation Renal Cell Carcinoma: Clinical Characteristics and Potential Prognostic Predictors. Dis Markers. 2021;2021:5647933. https:\/\/doi.org\/10.1155\/2021\/5647933.","journal-title":"Dis Markers"},{"issue":"1","key":"16463_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12894-020-00696-1","volume":"20","author":"W Zhuang","year":"2020","unstructured":"Zhuang W, Liu N, Guo HQ, Zhang CN, Gan WD. Gender diference analysis of Xp11.2 translocation renal cell carcinomas\u2019s attack rate: A meta-analysis and systematic review. BMC Urol. 2020;20(1):130. https:\/\/doi.org\/10.1186\/s12894-020-00696-1.","journal-title":"BMC Urol"},{"issue":"9","key":"16463_CR19","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.3390\/ijms21093378","volume":"21","author":"M Mancini","year":"2020","unstructured":"Mancini M, Righetto M, Baggio G. Gender-related approach to kidney cancer management: Moving forward. Int J Mol Sci. 2020;21(9):3378. https:\/\/doi.org\/10.3390\/ijms21093378.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16463_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/ajcp\/aqae011","volume":"162","author":"X Yin","year":"2024","unstructured":"Yin X, Hu X, Xu J, Xiong D, Zhao M. MED15:: TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis. Am J Clin Pathol. 2024;162(1):86\u201394. https:\/\/doi.org\/10.1093\/ajcp\/aqae011.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"16463_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-021-00790-3","volume":"19","author":"QC Shi","year":"2021","unstructured":"Shi QC, Liu N, Yang L, Chen Y, Lu YW, et al. Estradiol increases risk of topoisomerase II\u03b2-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma. Cell Commun Signal. 2021;19(1):114. https:\/\/doi.org\/10.1186\/s12964-021-00790-3.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"16463_CR22","doi-asserted-by":"publisher","first-page":"e15159","DOI":"10.1016\/j.heliyon.2023.e15159","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li X, Fan Y, Xu H, Gu Y, et al. Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities. Heliyon. 2023;9(4):e15159. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15159.","journal-title":"Heliyon"},{"issue":"11","key":"16463_CR23","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/jum.15951","volume":"41","author":"W Ma","year":"2022","unstructured":"Ma W, Zhang F, Huang H, Wang W, Zhu YQ, et al. Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes. J Ultrasound Med. 2022;41(11):2673\u201385. https:\/\/doi.org\/10.1002\/jum.15951.","journal-title":"J Ultrasound Med"},{"key":"16463_CR24","doi-asserted-by":"publisher","first-page":"151908","DOI":"10.1016\/j.anndiagpath.2022.151908","volume":"58","author":"R Feng","year":"2022","unstructured":"Feng R, Tao Y, Chen Y, Xu W, Zhang G, et al. Renal cancer associated with Xp11.2 translocation\/TFE3 gene fusion: Clinicopathological analysis of 13 cases. Ann Diagn Pathol. 2022;58:151908. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151908.","journal-title":"Ann Diagn Pathol"},{"key":"16463_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/j.sult.2016.11.001","volume":"38","author":"M Jinzaki","year":"2017","unstructured":"Jinzaki M, Silverman SG, Akita H, Mikami AJ, Oya M. Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types. Semin Ultrasound CT MRI. 2017;38:37\u201346. https:\/\/doi.org\/10.1053\/j.sult.2016.11.001.","journal-title":"Semin Ultrasound CT MRI"},{"issue":"4","key":"16463_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s13691-020-00430-6","volume":"9","author":"T Masago","year":"2020","unstructured":"Masago T, Kobayakawa S, Ohtani Y, Taniguchi K, Naka T, et al. Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review. Int Cancer Conf J. 2020;9(4):182\u20136. https:\/\/doi.org\/10.1007\/s13691-020-00430-6.","journal-title":"Int Cancer Conf J"},{"issue":"4","key":"16463_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.32074\/1591-951X-N1518","volume":"117","author":"S Marletta","year":"2025","unstructured":"Marletta S, Cali\u00f2 A, Fanelli GN, Bianco P, Bonadio AG, et al. TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey. Pathologica Sep. 2025;117(4):384\u201392. https:\/\/doi.org\/10.32074\/1591-951X-N1518.","journal-title":"Pathologica Sep"},{"issue":"5","key":"16463_CR28","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.21037\/jtd-21-1948","volume":"14","author":"R Ohira","year":"2022","unstructured":"Ohira R, Yanagawa M, Suzuki Y, Hata A, Miyata T, et al. CT-based radiomics analysis for differentiation between thymoma and thymic carcinoma. J Thorac Dis. 2022;14(5):1342\u201352. https:\/\/doi.org\/10.21037\/jtd-21-1948.","journal-title":"J Thorac Dis"},{"issue":"4","key":"16463_CR29","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1007\/s00330-021-08344-4","volume":"32","author":"NL Demirjian","year":"2022","unstructured":"Demirjian NL, Varghese BA, Cen SY, Hwang DH, Aron MJ, et al. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma. Eur Radiol. 2022;32(4):2552\u201363. https:\/\/doi.org\/10.1007\/s00330-021-08344-4.","journal-title":"Eur Radiol"},{"issue":"3","key":"16463_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060521997661","volume":"49","author":"Q Shi","year":"2021","unstructured":"Shi Q, Liu N, Zhu YQ, Qu F, Xu LF, et al. A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults. J Int Med Res. 2021;49(3):1\u201311. https:\/\/doi.org\/10.1177\/0300060521997661.","journal-title":"J Int Med Res"},{"key":"16463_CR31","doi-asserted-by":"publisher","first-page":"111774","DOI":"10.1016\/j.ijscr.2025.111774","volume":"135","author":"AA Djafari","year":"2025","unstructured":"Djafari AA, Samenezhad S, Hojjati SA, Rakhsha A, Rafighi D. Retained Surgicel mimicking renal tumor recurrence: A diagnostic pitfall following partial nephrectomy-A case report. Int J Surg Case Rep. 2025;135:111774. https:\/\/doi.org\/10.1016\/j.ijscr.2025.111774.","journal-title":"Int J Surg Case Rep"},{"key":"16463_CR32","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.radcr.2024.03.089","volume":"19","author":"AA Djafari","year":"2024","unstructured":"Djafari AA, Hojjati SA, Eslami AH, Samenezhad S, Faraji S. Does the use of Surgicel affect postsurgical radiological follow-up of kidney tumors? Radiol Case Rep. 2024;19:2856\u20138. https:\/\/doi.org\/10.1016\/j.radcr.2024.03.089.","journal-title":"Radiol Case Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16463-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16463-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16463-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:02:10Z","timestamp":1792432930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16463-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16463"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16463-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was granted ethical approval by the Institutional Review Board of Peking University First Hospital (approval number: 2024\u2009\u2212\u2009881) and strictly followed the relevant principles of the Declaration of Helsinki, with a waiver of written informed consent.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1247"}}